Generex Launches Generex Oral-lyn(TM) in Algeria
16 oct. 2009 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 16, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces USFDA Price Approval for Generex Oral-lyn(TM) in the Treatment IND Program
14 oct. 2009 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology to Hold Conference Call On Thursday to Update Investors On Generex Oral-lyn(TM) and Other Corporate Activities
14 oct. 2009 08h00 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Homeland Security TV Features Generex Executive to Discuss H1N1 Preparedness and Related Biological Security Issues
05 oct. 2009 09h15 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 5, 2009 (GLOBE NEWSWIRE) -- Dr. Eric von Hofe, PhD, President of Antigen Express, Inc. (www.antigenexpress.com), the wholly-owned immunotherapeutics subsidiary of Generex...
Generex Presents Abstracts At Scientific Symposium in Europe
30 sept. 2009 09h00 HE
|
Generex Biotechnology Corp.
45th Annual Meeting of the European Association for the Study of Diabetes
Vienna, Austria, 29 September - 2 October, 2009
WORCESTER, Mass., Sept. 30, 2009 (GLOBE NEWSWIRE) --...
Generex MENA Broadens International Reach
22 sept. 2009 10h54 HE
|
Generex Biotechnology Corp.
The Company's Branch Office in the United Arab Emirates Begins
Implementing Distribution Networks Outside of the Middle East and
North Africa
...
Generex to Raise $12,250,000 in Registered Direct Offering
14 sept. 2009 07h45 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces USFDA Approval of Use of Company's Flagship Buccal Insulin Product, Generex Oral-lyn(TM), Under the USFDA'S Treatment Investigational New Drug (IND) Program
10 sept. 2009 09h00 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex to Present At Rodman & Renshaw Annual Global Investment Conference
08 sept. 2009 10h18 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Establishes European Subsidiary
02 sept. 2009 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 2, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...